Akademik Veri Yönetim Sistemi
Çelen M. K.(Yürütücü), Ertürk Şengel B., Kaya Ş., Demirtürk N., Azap A., Pullukçu H., et al.
Şirket, 2020 - 2022
Objective: The aim of this study was to determine the rate of patients who receive HCV treatment after receiving positive anti-HCV results during HCV screening in Turkey during the last 3 years.
Patients and methods: This study was designed as a national, multi-center, cross-sectional, retrospective chart review study. Adult patients who received a positive anti-HCV result during HCV screening were included in this study. Data related to patients’ demographics, laboratory results, the time interval from obtaining a positive anti-HCV result to treatment initiation, the specialty of the physician requesting anti-HCV screening, type of hospital were collected and analyzed.
Results: Among 1000 patients who received a positive anti-HCV result, 50.3% were male and 78.5% were screened for HCV-RNA. Among HCV-RNA screened patients, 54.8% (n=430) had a positive result. The proportion of patients who received HCV treatment in line with their positive anti-HCV results in HCV-RNA positive patients was 72.8%. The median time from obtaining a positive anti-HCV result to initiation of HCV treatment was 91.0 days (IQR 42.0 to 178.5). Non-surgical branches requested HCV-RNA testing more frequently than surgical branches (p<0.001). The rate of access to HCV treatment was higher in patients screened in university hospitals than in patients screened in training and research hospitals (p<0.001).